ZFP36 and non-small cell lung carcinoma: The anti-cancer effects of resveratrol were also observed in non-small cell lung cancer (A549) cells, where through suppressed DNMT1 expression, resveratrol (20–100 μM; 72 h) reduced promoter methylation and upregulated the expression of the zinc finger protein 36 (ZFP36), leading to an inhibition in cell migration and proliferation [16].